Rajkumar Malayandi

12PUBLICATIONS
26CO-AUTHORS
Pharmaceutical delivery technologiesStructure and dynamics of materialsMolecular targetsTransport properties and non-equilibrium processesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 27, 2026
Understanding the Impact of Particle Size and Crystal Habit of Mesalamine Drug Substances on Their Packing, Wetting, and Dissolution Behaviour: A Science-based Approach for Selection of API Vendor.

|May 05, 2026
Understanding the Influence of Molarity, Buffer Capacity, and pH on Product-specific Guidance Dissolution Method for Developing a Discriminatory Dissolution Method for the Development of Mesalamine Products.

|May 05, 2026
Thermally Stressed Solid-State Stability of Semaglutide: Understanding the Influence of Temperature on Protein Content, Secondary Structure, Phase Transition, and Chemical Degradation.

|Apr 22, 2026
An In silico model-based feasibility assessment of erlotinib long-acting injectable formulation for the management of metastatic non-small cell lung cancer.

|Apr 20, 2026
Influence of pH, Buffering Capacity, Ionic Strength, Bile Salts, and Model Drugs on Micellization Behaviour of Salcaprozate Sodium in Physiological Range pH Buffers.

|Mar 23, 2026
In silico designing of palbociclib loaded PLGA long-acting intramuscular injection for palliative therapy of HR+/HER2- metastatic breast cancer.

Rutuja Suryawanshi, Anumol Joseph, Rajkumar Malayandi

Pageof 2

Frequent Collaborators

5 joint publications

Ankit Kumar

5 joint publications

Anumol Joseph

4 joint publications

Sadhana Dhyagala

4 joint publications

Adarsh Malgave